A triple negative breast cancer diagnosis, and the queer affirmation that kept her going - USA Today
A triple negative breast cancer diagnosis, and the queer affirmation that kept her going USA Today
A triple negative breast cancer diagnosis, and the queer affirmation that kept her going USA Today
Mom's Incorrect Cancer Diagnosis Caused Tragic Consequences for Her Family people.com
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk ScienceDaily
Tea for Two | Triangle event highlights breast cancer awareness, support ABC11 News
Art Bra Austin 2026 returns to raise funds for Breast Cancer Resource Center KXAN Austin
Breast cancer outbreak at Massachusetts high school prompts testing Fox 59
Why Breast Cancer Becomes More Aggressive with Age the-scientist.com
Rare Adenoid Cystic Breast Cancer in a Woman Medscape
Trodelvy Plus Keytruda Shows Lasting Benefit in Metastatic Breast Cancer Cure Today
Golf outing supports breast cancer awareness WAFB
How Cannabis Use May Be Accelerating Breast and Testicular Cancer Rates in AYAs The ASCO Post
Statin use after but not before breast cancer diagnosis is associated with improved mortality in hormone receptor-positive early breast cancer 2 Minute Medicine
Young woman rides waves of emotions after an invasive ductal breast cancer diagnosis at 36 while trying to start a family UCHealth
Golf outing supports breast cancer awareness WDBJ7
Golf outing supports breast cancer awareness WSAW
ASCO 2026: ADCs, KRAS Inhibitors & the Future of Breast Cancer Treatment with Dr Tarantino Targeted Oncology
79 An Exploration of the Influence of Adverse Childhood Experiences (ACEs) upon Symptom Burden & Tolerance of Anti-Estrogen Therapy (AET) in Breast Cancer Patients CancerNetwork
Golf outing supports breast cancer awareness FOX Carolina News
Full interview: Why Jamie Edmonds is going public with her breast cancer diagnosis ClickOnDetroit | WDIV Local 4
Switching to Camizestrant Upon ESR1 Mutation Detection Improves Outcomes in ER-Positive Breast Cancer Targeted Oncology
80 Datopotamab Deruxtecan (Dato-DXd) + Durvalumab (D) as First-Line (1L) Treatment (tx) for Unresectable Locally Advanced/Metastatic Triple-Negative Breast Cancer (a/mTNBC): Final Results From the Phase 1b/2 BEGONIA Study CancerNetwork
Giredestrant Plus Palbociclib Falls Short of Statistical Significance in Phase 3 Breast Cancer Trial Targeted Oncology
Brain-targeted estrogen reduces breast cancer treatment side effects News-Medical
Izalontamab Brengitecan Improves Survival in Triple-Negative Breast Cancer Oncology News Central
Elizabeth McDonald, MD, PhD, on GLP-1 Agonists and Breast Cancer Incidence The ASCO Post
20-Somethings Are Getting Double Mastectomies as Cancer Rates Rise in Young Adults WSJ
Nikon's Spatial Omics Analysis Software Technology to be Utilized in Joint Research on Breast Cancer Metastasis Led by the University of Tokyo | News Nikon
Northern Michigan’s Uncork Up North returns to support breast cancer patients 9and10News.com
Two-time breast cancer survivor urges early detection altoonamirror.com
Maryland woman diagnosed with cancer at 22 celebrates National Cancer Survivors' Month: "Please, don't give up" CBS News
Let’s Save Ma Honors Jersey City Medical Center for Advancing Women’s Health in Hudson County RWJBarnabas Health
Sacituzumab Govitecan Plus Pembrolizumab Improves PFS2 in TNBC Oncology News Central
Metastatic Breast Cancer: Current and Emerging Treatments Medscape Reference
83 Breast Cancer Prevalence Among Older Immigrant Women in the United States: A Cross-Sectional Study CancerNetwork
From Screening to Therapy: How AI Is Transforming Breast Cancer Detection and Treatment Decisions Docwire News
ESMO Updates Metastatic Breast Cancer Guideline: A More Molecular, Subtype-Driven Roadmap For Care Oncodaily
Dr Hurvitz on Gedatolisib's Superior Efficacy in PIK3CA+ Breast Cancer Targeted Oncology
Weight-loss drugs may cut breast cancer risk by up to 30%, study finds Yahoo Life UK
How breast cancer screening can predict heart disease risk Scientific American
84 Exceptional Responders in De Novo Metastatic Breast Cancer (dnMBC) Drug Cessation in Patients With HER2-Positive Metastatic Breast Cancer; Multicenter Retrospective Study CancerNetwork